International Assets Investment Management’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.3K Buy
81
+2
+3% +$1.13K ﹤0.01% 1358
2026
Q1
$45.1K Buy
79
+64
+427% +$31.9K ﹤0.01% 1259
2025
Q4
$7.31K Buy
+15
New +$6.99K ﹤0.01% 1736
2024
Q4
Sell
-57,694
Closed -$161 1891
2024
Q3
$161 Buy
57,694
+57,653
+140,617% +$19.5M ﹤0.01% 1573
2024
Q2
$13.1K Buy
+41
New +$10.9K ﹤0.01% 1585
2023
Q2
Sell
-65
Closed -$14.6K 1065
2023
Q1
$14.6K Buy
+65
New +$16K ﹤0.01% 823
2021
Q2
Sell
-76
Closed -$12K 1830
2021
Q1
$12K Buy
76
+38
+100% +$6.34K ﹤0.01% 1507
2020
Q4
$6K Buy
+38
New +$4.99K ﹤0.01% 1603

Other funds holding UTHR

International Assets Investment Management's UTHR Position: Q2 2026 in Review

International Assets Investment Management increased its United Therapeutics (UTHR) stake by 2.5% in Q2 2026, buying an estimated $1.13K and bringing the position to 81 shares worth $44.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1358.

International Assets Investment Management first reported a position in UTHR in Q4 2020 and has held it in 8 quarters since. The position peaked at $45.1K in Q1 2026. 281 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • International Assets Investment Management held 81 shares of United Therapeutics worth $44.3K as of Q2 2026.
  • International Assets Investment Management bought 2 United Therapeutics shares in Q2 2026, an estimated $1.13K.
  • United Therapeutics made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1358 holding.
  • International Assets Investment Management first reported a position in United Therapeutics in Q4 2020 and has held it in 8 quarters since.
  • International Assets Investment Management's United Therapeutics position peaked at $45.1K in Q1 2026.
  • 281 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.